chr6-31625782-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004638.4(PRRC2A):c.760-10C>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0026 in 1,568,688 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 18 hom. )
Consequence
PRRC2A
NM_004638.4 splice_polypyrimidine_tract, intron
NM_004638.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.004927
2
Clinical Significance
Conservation
PhyloP100: -0.145
Genes affected
PRRC2A (HGNC:13918): (proline rich coiled-coil 2A) A cluster of genes, BAT1-BAT5, has been localized in the vicinity of the genes for TNF alpha and TNF beta. These genes are all within the human major histocompatibility complex class III region. This gene has microsatellite repeats which are associated with the age-at-onset of insulin-dependent diabetes mellitus (IDDM) and possibly thought to be involved with the inflammatory process of pancreatic beta-cell destruction during the development of IDDM. This gene is also a candidate gene for the development of rheumatoid arthritis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 6-31625782-C-G is Benign according to our data. Variant chr6-31625782-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 3042147.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAdExome4 at 18 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRRC2A | NM_004638.4 | c.760-10C>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000376033.3 | |||
PRRC2A | NM_080686.3 | c.760-10C>G | splice_polypyrimidine_tract_variant, intron_variant | ||||
PRRC2A | XM_047419336.1 | c.760-10C>G | splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRRC2A | ENST00000376033.3 | c.760-10C>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_004638.4 | P1 | |||
PRRC2A | ENST00000376007.8 | c.760-10C>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | P1 | ||||
PRRC2A | ENST00000464890.1 | n.29C>G | non_coding_transcript_exon_variant | 1/3 | 2 | ||||
PRRC2A | ENST00000469577.5 | n.605-10C>G | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00198 AC: 301AN: 152012Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
301
AN:
152012
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00250 AC: 625AN: 250364Hom.: 5 AF XY: 0.00269 AC XY: 365AN XY: 135528
GnomAD3 exomes
AF:
AC:
625
AN:
250364
Hom.:
AF XY:
AC XY:
365
AN XY:
135528
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00267 AC: 3778AN: 1416558Hom.: 18 Cov.: 33 AF XY: 0.00276 AC XY: 1951AN XY: 707120
GnomAD4 exome
AF:
AC:
3778
AN:
1416558
Hom.:
Cov.:
33
AF XY:
AC XY:
1951
AN XY:
707120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00198 AC: 301AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.00184 AC XY: 137AN XY: 74360
GnomAD4 genome
AF:
AC:
301
AN:
152130
Hom.:
Cov.:
32
AF XY:
AC XY:
137
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PRRC2A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at